LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, a leading global eye health business, and Eton Pharmaceuticals, ...
LAVAL, QC, Feb. 23, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the U.S. launch of ...
The new formulation does not contain benzalkonium chloride. The Food and Drug Administration (FDA) has approved Alaway ® Preservative Free (ketotifen fumarate ophthalmic solution, 0.035%; Bausch + ...
Alimera Sciences Inc.'s first new drug application has won approval from the U.S. Food and Drug Administration. The three-year-old, Atlanta-based ophthalmic pharmaceutical company reported Dec. 5 the ...
Bausch + Lomb is adding a preservative-free formulation to its Alaway brand of antihistamine eye drops. Alaway Preservative Free marks the first and only preservative-free antihistamine eye itch ...
LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, a leading global eye health business, and Eton ...